Organogenesis Holdings (ORGO) Total Non-Current Liabilities (2017 - 2026)

Organogenesis Holdings' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $137.2 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 39.35% year-over-year to $137.2 million; the TTM figure through Mar 2026 stood at $137.2 million (up 39.35% YoY), while the FY2025 annual figure was $163.6 million, up 46.51% from the prior year.
• Total Non-Current Liabilities was $137.2 million for Q1 2026 at Organogenesis Holdings, down from $163.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $202.0 million in Q2 2022 to a low of $96.9 million in Q2 2025.
• Historically, Total Non-Current Liabilities has averaged $162.1 million across 5 years, with a median of $178.4 million in 2024.
• Biggest YoY gain for Total Non-Current Liabilities was 46.51% in 2025; the steepest drop was 45.69% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $182.6 million in 2022, then fell by 1.32% to $180.1 million in 2023, then slumped by 38.01% to $111.7 million in 2024, then surged by 46.51% to $163.6 million in 2025, then retreated by 16.17% to $137.2 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $137.2 million (Q1 2026), $163.6 million (Q4 2025), and $121.3 million (Q3 2025), per Business Quant data.